Principal Investigator : Institution:
Tissue Submitted By: Date: / /
Animal Number: Strain: Age: Weeks/Mo)
Experimental: Control: Carcinogen: Virus:
Specify Promotor(s): Specify Transgene(s): Genotype: /
Gender: M F No of Pregnancies: Days of Gestation/Lactation:
Date tumor first noted: / / Date of Sacrifice: / /
Fixative: Days of Fixation:
Processing: Routine (yes/no) ASAP(extra charge): (yes/no) Date: / /
Tissue Collected: (yes/no) Tissue Fixed: (yes/no) Tissue Frozen: (yes/no)
Mammary Gland Sampled: 1. Left Cervical (yes/no) 6. Right Cervical (yes/no)
2. Left Thoracic (yes/no) 7. Right Thoracic (yes/no)
3. Left Thoracic (yes/no) 8. Right Thoracic (yes/no)
4. Left Inguinal (yes/no) 9. Right Abdominal (yes/no)
5. Left Abdominal (yes/no)10.Right Inguinal (yes/no)
Tissues Sampled: A) Soft tissues:
Lung (yes/no) Liver (yes/no)
Brain (yes no) Lymph Nodes (yes/no)
Ovaries/Testis (yes/no) Adrenal glands (yes/no)
Pituitary (yes/no) Kidneys (yes/no)
Thymus (yes/no) Spleen (yes/no)
Other (specify):
Note: Please indicate site of lymph node sampling
B) Skeleton
Vertebrae (yes/no)
Femur (yes/no)
Unsubmitted Tissue Fixed For Future Study (yes/no)
Gross Description and Experimental Protocol
Principal Investigator : Institution:
Tissue Submitted By: Date: / /
Animal Number: Strain: Age: Weeks/Mo)
Experimental: Control: Carcinogen: Virus:
Specify Promotor(s): Specify Transgene(s): Genotype: /
Gender: M F No of Pregnancies: Days of Gestation/Lactation:
Fixative: Days of Fixation:
Date Received: / / Date of Processing: / /
Macroscopic Description of Tissue Received:
This should include the details on the request form, together with the
pathologists description before and after tissue slicing. The size
of any tumor or lesion identified should be measured in the maximum diameter
in mm. All abnormalities should be described.
A) BENIGN LESIONS:
Fibroadenoma (yes/no) Adenoma (yes/no)
Adenomyoepithelioma (yes/no)
Nuclear atypia present (yes/no)
Atypia Grade (High Intermediate - Low)
B) Epithelial Proliferation:
1. Acinar hyperplasia (yes/no)
Physiological Hyperplasia - increase in numbers of acini (yes/no)
GEM-induced Hyperplasia Alveolar: (yes/no) Ductal: (yes/no)
Focal: (yes/no) Multifocal: (yes/no) Diffuse: (yes/no)
2. Intra-luminal proliferation (yes/no)
Involves ducts: (yes/no) terminal duct lobular units: (yes/no) Unknown: (yes/no)
Epithelial proliferation without atypia: (yes/no)
Epithelial proliferation with atypia: (yes/no) Atypia Grade:(High - Intermediate -Low)
Focal: (yes/no) Multifocal: (yes/no) Diffuse: (yes/no)
Note: Epithelial proliferation with atypia is considered as Mammary Intraepithelial Neoplasia (MIN) by the Annapolis nomenclature
Maximum Diameters of Tumor: x (mm)
Tumor Pattern:(circle) Glandular Acinar Cribriform Papillary Solid Squamous
Other (specify):
Invasion:(yes/no) Vascular Invasion: (yes/no) Necrosis: (yes/no) Fibrosis: (yes/no)
Overall Grade: (circle) 1 2 3 not assessable
Mammary lymph nodes: Number positive: Total:
Other node metastases present: (yes/no) Number positive: Total:
Site of other nodes:
D) Metastases:
1. Lung metastases (yes/no) 2. Brain metastases (yes/no)
3. Liver metastases (yes/no) 4. Bone metastases (yes/no)
4. Report on other sites examined:
E) Description of Other Microscopic Findings:
Summary of Findings:
Pathologist: